Displaying drugs 15076 - 15100 of 15549 in total
Savolitinib
Savolitinib has been used in trials studying the treatment and health services research of Tumor, Food Effect, Gastric Cancer, Health Subjects, and Colorectal Cancer, among others.
Investigational
Matched Iupac: … 4-{1-[(1S)-1-{imidazo[1,2-a]pyridin-6-yl}ethyl]-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl}-1-methyl-1H-pyrazole …
Matched Description: … Savolitinib has been used in trials studying the treatment and health services research of Tumor, Food …
Matched Description: … Savolitinib has been used in trials studying the treatment and health services research of Tumor, Food …
Polmacoxib
Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Localized Primary Osteoarthritis of Hip, and Localized Primary Osteoarthritis of Knee.
Investigational
Matched Iupac: … 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl]benzene-1-sulfonamide …
Matched Description: … Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis …
Matched Categories: … COX-2 Inhibitors ... Selective Cyclooxygenase 2 Inhibitors (NSAIDs) …
Matched Description: … Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis …
Matched Categories: … COX-2 Inhibitors ... Selective Cyclooxygenase 2 Inhibitors (NSAIDs) …
Rebastinib
Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
Investigational
Matched Iupac: … -2-carboxamide ... 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine …
Matched Description: … Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
PF-04620110
PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).
Investigational
Matched Iupac: … 2-[(1r,4r)-4-(4-{4-amino-5-oxo-5H,6H,7H,8H-pyrimido[5,4-f][1,4]oxazepin-6-yl}phenyl)cyclohexyl]acetic …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 ... In Healthy Overweight Or Obese Subjects). …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 ... In Healthy Overweight Or Obese Subjects). …
Vunakizumab
Vunakizumab is under investigation in clinical trial NCT03463187 (Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis).
Investigational
Matched Description: … Vunakizumab is under investigation in clinical trial NCT03463187 (Multi-Dose Study of SHR-1314 in Subjects …
Norbixin
Norbixin is under investigation in clinical trial NCT03820245 (Effect of Short-term Annatto Carotenoids Supplementation on Oxidative Stress Status in Healthy Individuals).
Investigational
Matched Description: … Supplementation on Oxidative Stress Status in Healthy Individuals). ... Norbixin is under investigation in clinical trial NCT03820245 (Effect of Short-term Annatto Carotenoids …
Landipirdine
Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)).
Investigational
Matched Iupac: … {[(1R)-6-(3-fluorobenzenesulfonyl)-1,2,3,4-tetrahydronaphthalen-1-yl]methyl}urea …
Matched Description: … , Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)). ... Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety …
Matched Description: … , Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)). ... Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety …
Daxdilimab
Daxdilimab is under investigation in clinical trial NCT04526912 (Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection).
Investigational
Matched Description: … Injury (ALI) in Patients With COVID-19 Infection). ... Daxdilimab is under investigation in clinical trial NCT04526912 (Treatment and Prevention of Acute Lung …
PF-06273340
Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)).
Investigational
Matched Iupac: … N-{5-[2-amino-7-(1-hydroxy-2-methylpropan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl]pyridin-3-yl}- ... 2-(5-chloropyridin-2-yl)acetamide …
Matched Description: … Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration ... Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)). ... and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of …
Matched Description: … Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration ... Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)). ... and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of …
QRX-411
QRX-411 is a first-in-class RNA-based oligonucleotide designed to restore wild-type USH2A mRNA, leading to the production of the functional USH2A protein. It addresses the underlying cause of Usher syndrome due to the c.7595-2144A>G mutation in the USH2A gene.
Investigational
Matched Description: … QRX-411 is a first-in-class RNA-based oligonucleotide designed to restore wild-type USH2A mRNA, leading ... It addresses the underlying cause of Usher syndrome due to the c.7595-2144A>G mutation in the _USH2A_ …
Lersivirine
Lersivirine has been used in trials studying the treatment of HIV-1.
Investigational
Matched Iupac: … 5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile …
Matched Description: … Lersivirine has been used in trials studying the treatment of HIV-1. …
Matched Description: … Lersivirine has been used in trials studying the treatment of HIV-1. …
Laninamivir octanoate
Laninamivir octanoate has been used in trials studying the treatment of Asthma.
Investigational
Matched Iupac: … (2R,3R,4S)-4-carbamimidamido-3-acetamido-2-[(1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl]-3,4-dihydro …
Matched Description: … Laninamivir octanoate has been used in trials studying the treatment of Asthma. …
Matched Description: … Laninamivir octanoate has been used in trials studying the treatment of Asthma. …
Semapimod
Semapimod has been used in trials studying the treatment of Crohn Disease.
Investigational
Matched Description: … Semapimod has been used in trials studying the treatment of Crohn Disease. …
Matched Salts cas: … 872830-80-3 ... 164301-51-3 …
Matched Salts cas: … 872830-80-3 ... 164301-51-3 …
Namitecan
Namitecan has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Iupac: … ^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione ... (19S)-10-[(1E)-[(2-aminoethoxy)imino]methyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0 …
Matched Description: … Namitecan has been used in trials studying the treatment of Solid Tumors. …
Matched Description: … Namitecan has been used in trials studying the treatment of Solid Tumors. …
BLXA4
BLXA4 has been used in trials studying the treatment of Gingival Inflammation.
Investigational
Matched Iupac: … (5S,6R,7E)-5,6-dihydroxy-8-{2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]phenyl}oct-7-enoic acid …
Matched Description: … BLXA4 has been used in trials studying the treatment of Gingival Inflammation. …
Matched Description: … BLXA4 has been used in trials studying the treatment of Gingival Inflammation. …
Secoisolariciresinol
Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Iupac: … (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol …
Matched Description: … Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer. …
Matched Description: … Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer. …
Talsaclidine
Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Iupac: … (3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane …
Matched Description: … Talsaclidine has been used in trials studying the treatment of Alzheimer Disease. …
Matched Description: … Talsaclidine has been used in trials studying the treatment of Alzheimer Disease. …
Piromelatine
Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Iupac: … N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-oxo-4H-pyran-2-carboxamide …
Matched Description: … Piromelatine has been used in trials studying the treatment of Alzheimer's Disease. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … Piromelatine has been used in trials studying the treatment of Alzheimer's Disease. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
GLPG-0187
GLPG0187 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Iupac: … (2S)-3-({2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl}amino ... )-2-(4-methoxybenzenesulfonamido)propanoic acid …
Matched Description: … GLPG0187 has been used in trials studying the treatment of Solid Tumors. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … GLPG0187 has been used in trials studying the treatment of Solid Tumors. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Semagacestat
Semagacestat has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Iupac: … (2S)-2-hydroxy-3-methyl-N-[(1S)-1-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]carbamoyl …
Matched Description: … Semagacestat has been used in trials studying the treatment of Alzheimer Disease. …
Matched Description: … Semagacestat has been used in trials studying the treatment of Alzheimer Disease. …
Lecozotan
Lecozotan has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Iupac: … 4-cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]propyl]-N-(pyridin-2-yl)benzamide …
Matched Description: … Lecozotan has been used in trials studying the treatment of Alzheimer Disease. …
Matched Description: … Lecozotan has been used in trials studying the treatment of Alzheimer Disease. …
BMS-911543
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Matched Iupac: … N,N-dicyclopropyl-7-[(1,5-dimethyl-1H-pyrazol-3-yl)amino]-10-ethyl-3-methyl-3,5,8,10-tetraazatricyclo …
Matched Description: … BMS-911543 has been used in trials studying the treatment of Cancer. …
Matched Categories: … Janus Kinase 2, antagonists & inhibitors …
Matched Description: … BMS-911543 has been used in trials studying the treatment of Cancer. …
Matched Categories: … Janus Kinase 2, antagonists & inhibitors …
Mibampator
Mibampator has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Iupac: … N-[(2R)-2-[4'-(2-methanesulfonamidoethyl)-[1,1'-biphenyl]-4-yl]propyl]propane-2-sulfonamide …
Matched Description: … Mibampator has been used in trials studying the treatment of Alzheimer's Disease. …
Matched Description: … Mibampator has been used in trials studying the treatment of Alzheimer's Disease. …
Merotocin
Merotocin has been used in trials studying the treatment of Preterm Delivery.
Investigational
Matched Description: … Merotocin has been used in trials studying the treatment of Preterm Delivery. …
PF-00217830
PF-00217830 has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Iupac: … 7-{4-[4-(naphthalen-1-yl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydro-1,8-naphthyridin-2-one …
Matched Description: … PF-00217830 has been used in trials studying the treatment of Schizophrenia. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … PF-00217830 has been used in trials studying the treatment of Schizophrenia. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Displaying drugs 15076 - 15100 of 15549 in total